Werewolf Therapeutics Inc. Gains 34.83%
Wed, Oct 25, 2023 at 07:24 PM
Werewolf Therapeutics Inc. (HOWL:NASDAQ) soared at $2.4, a gain of 34.8%. On Wed, Oct 25, 2023, HOWL:NASDAQ hit a New 2-Week Intraday High of $2.65. The stock appeared on our News Catalysts scanner on Thu, Sep 28, 2023 at 04:47 AM in the 'BIOTECH' category. From Wed, Oct 11, 2023, the stock recorded 60.00% Up Days and 45.45% Green Days
About Werewolf Therapeutics Inc. (HOWL:NASDAQ)
Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.
Top 10 Gainers:
- Abri SPAC I Inc. (ASPA:NASDAQ), 116.4%
- Nuvve Holding Corp. (NVVE:NASDAQ), 61.27%
- Aclarion Inc. (ACON:NASDAQ), 42.86%
- Werewolf Therapeutics Inc. (HOWL:NASDAQ), 34.83%
- Fujian Blue Hat Interactive Entertainment Technology Ltd. (BHAT:NASDAQ), 33.64%
- Vinco Ventures Inc. (BBIG:NASDAQ), 33.33%
- Li-Cycle Holdings Corp. (LICY:NYSE), 32.71%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 25.8%
- Elys Game Technology Corp. (ELYS:NASDAQ), 24.94%
- Catalyst Biosciences, Inc. (CBIO:NASDAQ), 22.91%